Sotio

Prague, Czech Republic

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

$316.6M raised

Dec 2021

Private Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sotio raised?

Sotio has raised $316.6M in total funding. The most recent round was Private Equity. The last funding was announced in December 2021.

Who are Sotio's investors?

Sotio's investors include PPF Group.

Where is Sotio headquartered?

Sotio is headquartered in Prague, Czech Republic.

What does Sotio do?

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

What stage is Sotio at?

Sotio is at the Private Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 2, 2021.

MLA

"Sotio — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/sotio. Accessed July 2, 2026.

APA

VCBacked. (2021). Sotio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sotio

Wikipedia (cite web)

{{cite web |title=Sotio — Funding & Investors |url=https://www.vcbacked.co/company/sotio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 2, 2021.